The inhibition by calmodulin of thyroid-stimulating hormone binding to epididymal fat, testis and thyroid membranes in the guinea-pig.
Calmodulin inhibited 125I-labelled TSH binding to the membranes of various target tissues for TSH (thyroid, epididymal fat and testis) of the guinea-pig. This inhibition was abolished by adding EGTA (1 mmol/l). Calmodulin did not inhibit the binding of 125I-labelled epidermal growth factor (EGF) to these membranes. It is suggested that the inhibitory effect of calmodulin on the binding of TSH to the receptor is specific and that this mechanism is due to the direct binding of calmodulin to receptor membranes. The ability of calmodulin to bind to the membranes was calcium-sensitive while that of TSH was not. The binding of 125I-labelled calmodulin to these membranes increased significantly when the endogenous calmodulin in the membranes was removed by EGTA. It was not inhibited by a pure preparation of TSH, but it was inhibited by contaminated calmodulin in a crude TSH preparation. On the other hand, 125I-labelled TSH binding to these membranes did not change after the removal of endogenous calmodulin. In conclusion, exogenous calmodulin has an inhibitory effect on the binding of TSH but not of EGF to the membranes of guinea-pig thyroid, epididymal fat and testis.
Inui
T
T
Central Clinical Laboratory, Shiga University of Medical Science, Japan.
Ochi
Y
Y
Hachiya
T
T
Kajita
Y
Y
Ishida
M
M
Nakajima
Y
Y
Nagamune
T
T
D000818:Animals; D002147:Calmodulin / Q000494:pharmacology / Q000502:physiology*; D004815:Epidermal Growth Factor / Q000378:metabolism; D004822:Epididymis / Q000187:drug effects / Q000378:metabolism*; D006168:Guinea Pigs; D008297:Male; D011485:Protein Binding / Q000187:drug effects; D013737:Testis / Q000187:drug effects / Q000378:metabolism*; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism*; D013972:Thyrotropin / Q000378:metabolism* / Q000494:pharmacology
D002147:Calmodulin; D004815:Epidermal Growth Factor; D013972:Thyrotropin